{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:19Z","timestamp":1783606939504,"version":"3.55.0"},"reference-count":34,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>Measurements of plasma free metanephrines provide a highly sensitive test for the diagnosis of pheochromocytoma\/paraganglioma (PPGL). However, false-positive results remain common, posing a diagnostic dilemma for clinicians. The aim of this study was to determine whether chronic illness and commonly prescribed drugs can falsely elevate plasma free metanephrines. This retrospective study included 460 patients without PPGL. Disease exclusion was based on negative imaging or histopathological findings, or negative biochemistry at follow-up. Sex, age, plasma free normetanephrine, metanephrine, and methoxytyramine, the presence or absence of cardiometabolic comorbidities and\/or chronic illness (CCI), and all prescribed medications at study inclusion were reported. In four patients under treatment with norepinephrine reuptake blockers (NRBs), metanephrines were measured at baseline and after short-term discontinuation of the drug. Among the 460 patients without PPGL, 88% (407\/460) were receiving at least one medication. In this cohort, false-positive elevations of plasma free metanephrines were rare (7%). Multivariable analysis identified NRBs as the only drugs independently associated with increased plasma free normetanephrine levels (P &amp;lt; 0.001), in a dose-dependent manner. Importantly, plasma free methoxytyramine concentrations were independently influenced by NRBs, antipsychotics, and nicotine use (P &amp;lt; 0.001). Paired analyses in a subset of four patients before and after short-term NRB withdrawal showed normalization of plasma free normetanephrine concentrations. Plasma free metanephrines show high diagnostic reliability with minimal interference from CCI or commonly used medications. However, NRBs can increase normetanephrine and methoxytyramine concentrations, particularly at higher doses, and thus, their use requires cautious interpretation of plasma free metanephrine measurements.<\/jats:p>","DOI":"10.1530\/erc-25-0549","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:54:01Z","timestamp":1776696841000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of false-positive plasma free metanephrines and methoxytyramine: the role of medications and chronic disease"],"prefix":"10.1530","volume":"33","author":[{"given":"Lara M","family":"Knigge","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Potthoff","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Fuld","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Zawadzka","sequence":"additional","affiliation":[{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermal","family":"Tahirukaj","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bornstein","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-1604","authenticated-orcid":true,"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026070909453383300_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070909453383300_bib2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453383300_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","article-title":"International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents","volume":"20","author":"Casey","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026070909453383300_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"2026070909453383300_bib5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453383300_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","author":"D\u00e4rr","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2026070909453383300_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-13-0673","article-title":"Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma","volume":"170","author":"Pamporaki","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026070909453383300_bib8","doi-asserted-by":"crossref","first-page":"e3689","DOI":"10.1210\/clinem\/dgac390","article-title":"Preanalytical considerations and outpatient versus inpatient tests of plasma metanephrines to diagnose pheochromocytoma","volume":"107","author":"Pommer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453383300_bib9","first-page":"528","article-title":"Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients","volume":"1","author":"Schmidt","year":"1996","journal-title":"Eur J Med Res"},{"key":"2026070909453383300_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"key":"2026070909453383300_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026070909453383300_bib12","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909453383300_bib13","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0063","article-title":"False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade","volume":"31","author":"Sch\u00fcrfeld","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026070909453383300_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.322.7296.1213","article-title":"Drug points: pseudophaeochromocytoma syndrome associated with clozapine","volume":"322","author":"Krentz","year":"2001","journal-title":"BMJ"},{"key":"2026070909453383300_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.90.1.248","article-title":"Mechanisms responsible for sympathetic activation by cigarette smoking in humans","volume":"90","author":"Grassi","year":"1994","journal-title":"Circulation"},{"key":"2026070909453383300_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0895-7061(98)00022-3","article-title":"Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men","volume":"11","author":"Mundal","year":"1998","journal-title":"Am J Hypertens"},{"key":"2026070909453383300_bib17","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2016.06.004","article-title":"No influence of antihypertensive agents on plasma free metanephrines","volume":"49","author":"Osinga","year":"2016","journal-title":"Clin Biochem"},{"key":"2026070909453383300_bib18","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1373\/clinchem.2006.070805","article-title":"Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population","volume":"52","author":"Brain","year":"2006","journal-title":"Clin Chem"},{"key":"2026070909453383300_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"2026070909453383300_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","author":"Eisenhofer","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"2026070909453383300_bib21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(69)90637-0","article-title":"Plasma catecholamines after cardiac infarction","volume":"294","author":"McDonald","year":"1969","journal-title":"Lancet"},{"key":"2026070909453383300_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2362.1970.tb00600.x","article-title":"Urinary excretion of catecholamines and their main metabolites after myocardial infarction: relationship to the clinical syndrome","volume":"1","author":"Jequier","year":"1970","journal-title":"Eur J Clin Invest"},{"key":"2026070909453383300_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jcp.2006.036640","article-title":"Catecholamine and metanephrine excess in intracerebral haemorrhage: revisiting an obscure yet common pseudophaeochromocytoma","volume":"60","author":"Leow","year":"2007","journal-title":"J Clin Pathol"},{"key":"2026070909453383300_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jcp.2003.013201","article-title":"Urinary catecholamines and metabolites in the immediate postoperative period following major surgery","volume":"57","author":"Syed","year":"2004","journal-title":"J Clin Pathol"},{"key":"2026070909453383300_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2006.10.001","article-title":"Catecholamines, infection and death in acute ischaemic stroke","volume":"252","author":"Chamorro","year":"2007","journal-title":"J Neurol Sci"},{"key":"2026070909453383300_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"2026070909453383300_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3999(04)00064-9","article-title":"Depression and anxiety symptoms are related to increased 24 hour urinary norepinephrine excretion among healthy middle-aged women","volume":"57","author":"Hughes","year":"2004","journal-title":"J Psychosom Res"},{"key":"2026070909453383300_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2018.06.018","article-title":"Optimized reference intervals for plasma free metanephrines in patients with CKD","volume":"72","author":"Pamporaki","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026070909453383300_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94104-9","article-title":"Optimized procedures for testing plasma metanephrines in patients on hemodialysis","volume":"11","author":"Pamporaki","year":"2021","journal-title":"Sci Rep"},{"key":"2026070909453383300_bib30","first-page":"R817","article-title":"Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans","volume":"260","author":"Esler","year":"1991","journal-title":"Am J Physiol"},{"key":"2026070909453383300_bib31","first-page":"R824","article-title":"Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits","volume":"260","author":"Eisenhofer","year":"1991","journal-title":"Am J Physiol"},{"key":"2026070909453383300_bib32","first-page":"107","article-title":"Comparison of the effect of reversible and irreversible MAO inhibitors on renal nerve activity in the anesthetized rat","volume":"41","author":"Lavian","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"2026070909453383300_bib33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Therapeut"},{"key":"2026070909453383300_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41440-020-0406-4","article-title":"Clinical factors affecting spot urine fractionated metanephrines in patients suspected phaeochromocytoma\/paraganglioma","volume":"43","author":"Bokuda","year":"2020","journal-title":"Hypertens Res"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/5\/ERC-25-0549.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/5\/ERC-25-0549.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0549\/506053\/erc-25-0549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0549\/506053\/erc-25-0549.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:45:45Z","timestamp":1783604745000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/5\/e250549\/75559\/Determinants-of-false-positive-plasma-free"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0549","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"e250549"}}